Patents

Nissim Garti, Lewis G Jacobs, Branin Lane, and Imad. Zakharia. 2003. “Isotropic transparent aqueous compositions containing fat soluble vitamins, an alc. and a surfactant.” United States of America (WO2003063617A1). Abstract
Disclosed are compns. for dispersion of a fat-sol. vitamin to give a clear, stable soln. of the vitamin, the compns. comprising the vitamin, an alc., a surfactant, and water. Also disclosed are dried powder compns. comprising a fat-sol. vitamin which upon mixing with an aq. soln. form an isotropic transparent soln., said compns. comprising the vitamin, an oil, a surfactant, and a sugar alc. [on SciFinder(R)]
Nissim Garti, Morris Zelkha, and Tanya. Sedlov. 2003. “Carotenoid formulation.”. Abstract
The present invention discloses the use of a lycopene coated with a water non-sol. thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5 %. The invention further discloses a process for the prepn. of stable lycopene formulation comprising: (a) treating an isolated protein to form a protein in a mol. form; (b) dispersing lycopene in an aq. soln. comprising an isolated protein in a mol. form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 $μ$m forming an homogenized mixt. comprising fine particles; and optionally (d) drying the homogenized mixt. [on SciFinder(R)]
Nissim Garti. 2002. “Nano-sized self-assembled structured liquids.” United States of America 10/173,508 (USA Application ). Abstract

Patent number by country:
Europe: Application No. 03730446.6
Australia: Application No. 2003241126,
Canada: Application No. 2,488,501,
China: Application No. 03813735.6
Israel: Application No. 165528,
Japan: Application No. 512525/04,

 

Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Lieberman, and Neomi. Gershon. 2002. “New crystal forms of lamotrigine and processes for their preparations.” Canada CA2439468. Abstract
The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine-contg. mols. of the solvent in stoichiometric ratios are disclosed. Processes for prepg. the new crystal forms of lamotrigine and dosage forms are also provided. For example, 2 g of lamotrigine anhyd. and about 80 mL of ethanol were charged in a three-necked bottomed round flask equipped with a mech. stirrer, a condenser and a thermometer. The suspension was stirred for about 24 h without heating at about 25° and the solid phase was sepd. by filtration, producing lamotrigine Form H, i.e., lamotrigine ethanol monosolvate. [on SciFinder(R)]
Nissim Garti, Abraham Aserin, Zecharia Madar, and Boaz. Sternheim. 1999. “Galactomannan products and compositions containing the same.” Germany DE69510920T. Abstract
A galactomannan isolated from fenugreek seed has ≥50 repeating units of mannose and galactose in a ratio of 0.5-1.0 and 1.8-1.0, a protein content of ≤20%, a saponin content of ≤5%, and a lipid content of ≤1%, and is useful as an active ingredient in nutraceutical and cosmetic products. [on SciFinder(R)]

Pages